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SummaryThis study presented a
method of plan selection in
intensity modulated proton
therapy to address the chal-
lenge of delivering treatment
to the prostate and the pelvic
lymph nodes with different
motion patterns. The plan
library used different posi-
tions of the prostate created
from a population model of
day-to-day target motion.
Plan selection from this
library reduced the dose to
the rectum and bladder
without compromising target
coverage compared with
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https://doi.org/10.1016/j.ijrobp.2019.11.007Purpose: Intensity modulated proton therapy (IMPT) of locally advanced prostate cancer
can spare the bowel considerably compared with modern photon therapy, but simulta-
neous treatment of the prostate (p), seminal vesicles (sv), and lymph nodes is challenging
owing to day-to-day organ motion and range uncertainties. Our purpose was, therefore, to
generate a plan library for use in adaptive IMPT to mitigate these uncertainties.
Methods and Materials: We retrospectively included 27 patients with a series of
computed tomography scans throughout their treatment representing day-to-day varia-
tion. In 18 of the patients, target motion was analyzed using rigid shifts of prostate gold
markers relative to bony anatomy. A plan library with different p and sv planning target
volume (p/sv-PTV) positions was defined from the distribution and direction of these
shifts. Delivery of IMPT using plan selection from the library was simulated for image
guidance on bony anatomy, in the remaining patients and compared with nonadaptive
IMPT.
Results: The plan library consisted of 3 small margin p/sv-PTVs: (1) p/sv-PTV shifted
1.5 systematic error (S) of the population mean in the anterior and cranial directions,
(2) p/sv-PTV shifted 1.5S in the posterior and caudal directions, and (3) p/sv-PTV in
the planning position. The conventional p/sv-PTV was also available for backup. Plan
selection compared with nonadaptive IMPT resulted in a reduction of the rectum volume
receiving 60 Gy relative biological effect (RBE) (V60GyRBE) from on average 12 mL to 9
mL. For the bladder the average V45GyRBE was reduced from 36% to 30%. Large and
small bowel doses were also reduced, whereas target coverage was comparable or
improved compared with nonadaptive IMPT.E-mail: sara.thornqvist@
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Volume 106  Number 3  2020 Plan selection in proton therapy 631Conclusions: Plan selection based on a population model of rigid target motion was
feasible for all patients. Compared with conventional IMPT, plan selection resulted in sig-
nificant dosimetric sparing of rectum and bladder without compromising target coverage.
 2019 The Author(s). Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Day-to-day organ motion is a challenge for accurate
treatment delivery in modern radio- and especially in
intensity modulated proton therapy (IMPT). The greater
sensitivity to motion for protons is due to their finite
range in addition to elevated dose deposited at the end of
their paths, which can cause deterioration of the dose
distribution if the planning anatomy deviates from the
treated. For passive scattering proton therapy (PT) of
localized prostate cancer, both variations in bony anat-
omy (BA) and soft-tissue deformation prevent margin
reductions.1 In prostate cancer, the benefits of PT from
increased dose conformity lead to normal tissue sparing,
and in regard to bowel could be greater for locally
advanced than for localized disease.2 Still, margins to
account for target motion may cause high exposure of
surrounding organs at risk while resulting in unsatisfac-
tory dose coverage of the target.3,4 The addition of the
pelvic lymph nodes further increases the treatment
complexity because the motion of the pelvic lymph
nodes differs from those of the prostate and seminal
vesicles.3,5-8
One method to limit the impact of day-to-day organ
motion is through an adaptive delivery approach. In adap-
tive PT of prostate cancer, simulation studies have mainly
concerned online replanning.4,9,10 Online replanning has
also been studied for photon radiation therapy, but the
additional workload required, for example, for contouring
and plan quality assurance, has obstructed the vast majority
of the simulation studies from reaching clinical practice.11
Plan selection has, however, been implemented success-
fully across several pelvic sites and enabled normal tissue
sparing in photon radiation therapy.12-17 For locally
advanced prostate cancer, Xia et al constructed a plan li-
brary for rigid shifts of the prostate relative to the pelvic
lymph nodes for 1 patient to reduce rectum dose.12 This
plan selection procedure has the potential to reduce the
impact of range uncertainty in PT caused by altered bony
anatomy1 while reducing target margins. In our study, we
wanted to describe a method of deriving a plan library
using conventional margin recipe for motion and evaluate
the potential in IMPT. We hypothesize that selection from a
plan library with different positions of the prostate and
seminal vesicle planning target volumes (p/sv-PTV) in
relation to the lymph node target can improve sparing of
normal tissue while maintaining coverage for all targets
compared with nonadaptive IMPT.Methods and Materials
The study included 27 patients previously treated for
locally advanced prostate cancer with intensity modulated
radiation therapy (IMRT). The regional ethical committee
of western Norway approved the original dose escalation
study and each patient gave an informed consent before
participation to undergo additional imaging. Each patient
was represented by a planning computed tomography
(pCT) and 6 to 10 repeat CTs (rCTs) (average: 9 rCTs)
acquired evenly throughout the course of treatment,
roughly corresponding to 2 rCTs per full treatment week
and avoiding scans on successive days. All patients had 3
fiducial gold-markers (GMs) implanted in the prostate
before acquiring the pCT, and the course of IMRT was
delivered with image guidance primarily on GM with
translational correction of the patient position. For the
pCT, bladder contrast was injected to aid bladder and
prostate differentiation (contrast overwritten to water
equivalent for planning). Identical patient fixation was for
all CTs and no laxatives administrated.
Three targets were defined in the pCTs and in the rCTs:
the prostate clinical target volume (p-CTV) as the prostate
gland including capsule and possible extraglandular tumor
extension, the combined prostate and seminal vesicle CTV
(p/sv-CTV) as the p-CTV extended with seminal vesicles,
and the lymph node CTV (ln-CTV) as the p/sv-CTV
extended with pelvic lymph nodes. The lymph nodes were
contoured according to Radiation Therapy Oncology
Group guidelines, but omitting the presacral nodes.6
Additionally, organs at risk were contoured in all CTs
with bladder and rectum manually segmented to encom-
pass organ with content.18 Large bowel was defined from
the cranial end of the rectum to above the cranial part of
the lymp node PTV (ln-PTV) and included sigmoid and
descending colon. Small bowel was defined as the
remaining bowel loops within the cranio-caudal extensions
of the large bowel. Further details on the patient material
and the IMRT treatment procedure for these patients can
be found elsewhere.19,20The population-model of day-to-day motion for
plan library construction
The patients were partitioned into a training set consisting
of the first 18 patients and a testing set consisting of the 9
remaining patients. From the training set, a day-to-day
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p-CTV in relation to ln-CTV, substituted by the intra-
prostatic GMs and pelvic BA, respectively. The global
translation in the lateral, longitudinal, and vertical direc-
tions to align each rCT i (i Z 1.N) to the pCT for every
patient, k (k Z 1.18) was described by the vector, vi;kGMfor
GM- and vi;kBA for BA-based registrations. The residual
motion vector, vi;kresZv
i;k
GM  vi;kBA was assumed to capture the
residual motion of the p-and p/sv-CTVs relative to the ln-
CTV when positioning the patient on BA. In total, 160
rCTs were used to quantify the residual motion vector. The
normality of the motion was checked visually by Quantile-
Quantile plots and histograms.
The magnitude of p- and p/sv-CTV day-to-day motion in
the patient population was estimated from the systematic
uncertainty ðSÞ and random (s) uncertainties, commonly
used in margin recipes.21,22 The s was, therefore, estimated






vi;kres: The systematic difference in
residual motion between planning and treatment, S was
calculated as the direction-specific standard deviation of the




conventional plan used in the nonadaptive delivery, the p-
and p/sv-CTV were expanded according to van Herk et al
securing high (>95%) target coverage in 90% of the pop-
ulation.22 This plan also was used for backup in the plan
library and will hereafter also be referred to as “the backup
plan.” Our purpose was to differentiate the day-to-day
motion using displaced positions of the p-and p/sv-CTV
such that, instead of having a large PTV accounting for
most of the residual motion, patients with greater system-
atic error (or instances with large residual motion) would be
treated with a displaced CTV. The factor of the systematic
error determines the fraction of patients who receive dose
above a certain threshold.22 The PTV expansion was,
therefore, reduced to cover 50% of the population instead
of 90% by changing the factor of the systematic error from
2.5 to 1.5 and neglecting random uncertainties. The
selected 50% confidence level was a compromise between
our intention to have the original position selected most
frequently but yet avoid a large PTV and instead have the
displaced targets selected for the outlier positions or large
residual motion. The PTV expansion due to motion was for
simplicity used for all plans (except for the backup plan) in
the library.
Similarly, the displaced p-and p/sv-CTVs were obtained
by translating the original p-and p/sv-CTV position by
1.5S. To facilitate the manual plan selection, we wanted
to reduce the number of plans in the library as much as
possible without compromising prediction of the most
probable p/sv-CTV positions. This was done by analyzing
the pairwise correlation of vi;kresðx; yÞ; vi;kresðx; zÞ; vi;kresðy; zÞ and
adapting the displaced positions to account for possible
correlations. Furthermore, displacements less than 3 mm in
any of the anatomic directions were neglected as a pragmaticsolution to reduce the number of treatment plans in the
library.
The resulting plan library consequently contained plans
with a linear combination of p- and p/sv-PTV positions
along the main directions of day-to-day motion in addition
to 2 p- and p/sv-PTVsd1 with a small and 1 with a con-
ventional margindin the original planning position. IMPT
with the nonadaptive delivery of the conventional plan was
subsequently compared with the adaptive approach of plan
selection from the constructed libraries.
Treatment planning and delivery simulations
The nonadaptive and adaptive approach of treatment de-
livery was simulated for 9 testing patients. For these pa-
tients, IMPT plans with 2 lateral opposing fields and a
constant relative biological effect (RBE) of 1.1 were opti-
mized in Eclipse treatment planning system (Varian medi-
cal systems, Palo Alto, US). The prescription for all plans
was 67.5 Gy(RBE) to the p-PTV, 60 Gy(RBE) to the p/sv-
PTV, and 50 Gy(RBE) to the ln-PTV delivered as a
simultaneous integrated boost in 25 fractions. As previously
described, the p-and p/sv-PTVs were defined using the
population-model for both the adaptive and nonadaptive
delivery approaches. In the plan library, only the p- and
p/sv-PTVs were shifted on the pCT, with the segmentation
for the rectum, bowel, and intestine remaining unchanged.
The ln-PTV was expanded isotopically by 5 mm for both
delivery approaches, based on results from previous motion
studies.5,23 Field-specific lateral, proximal, and distal mar-
gins used for IMPT planning to increase robustness were 10
mm, 1 mm, and 2 mm, respectively.
All plans (original p- and p/sv-PTVs and those shifted)
had the goal to satisfy the following dose criteria (in order
of prioritisation): PTV D98% > 95% of the prescribed dose,
rectum V60GyRBE < 10 mL, bladder V45GyRBE < 35%, in-
testine, that is, the defined small and large bowel loops
V40GyRBE < 30%.
For treatment simulation, the IMPT plans of the pCTwere
transferred to the rCTs using BA registration followed by
dose recalculations such that the planned proton fluences and
spot distribution were delivered for the new patient geome-
try. For the nonadaptive approach, only the plan with con-
ventional margins was available for treatment. The adaptive
approach used a selection of plans from the libraries. The
plans with p/sv-PTV that geometrically encompassed the
p/sv-CTV in each of the rCT were selected for treatment. If
this was fulfilled by several PTVs in the library, the one with
least geometric amount of overlap with the organs at risk of
the rCT was selected. All selections were made visually, and
to evaluate consistency of the procedure, the selection was
made independently by 2 medical physicists and differences
were reviewed for agreement. Only the selected plan was
transferred to the rCT followed by a dose recalculation. The
dose recalculations were performed subsequent to all selec-
tions and blinded to the physicists making the selections.
Volume 106  Number 3  2020 Plan selection in proton therapy 633The simulated dose delivered with the adaptive and
the nonadaptive approach was compared for all CTVs
using D98% and for organs at risk using generalized
equivalent uniform dose (gEUD) for rectum (with the
volume factor, k Z 12), bladder (k Z 8), small (k Z 4),
and large bowel (k Z 4) in addition to the dose criteria
used for planning. The obtained dose-volume parameters
(D98%, V60GyRBE, V45GyRBE, V40GyRBE,) and gEUD from
each rCTs were averaged for all rCTs and patients, and
these distributions were checked for normality before
statistical testing. The averages of the dose parameters
from the adaptive and the nonadaptive approach were
compared with a paired test (t test for normally distrib-
uted data and Wilcoxon signed rank for non-normal data)
with significance of P  .05.Results
Plan library composition
The greatest variation of residual p- and p/sv-CTVmotion was
seen in the anterioreposterior and the caudalecranial direc-
tion, bothwithS of 3mm,whereas theS for righteleftmotion
was less than 1mm (Fig. E1; available online at https://doi.org/
10.1016/j.ijrobp.2019.11.007). Noticeable linear correlation
was only found in the caudalecranial and anterioreposterior
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Fig 1. Creation of the plan library. (A) The difference in gold
patients denoted with crosses of different colors. Large crosses d
(CTV) with plan up (green), plan mid (orange), and plan down (b
seminal vesicles CTV in a testing patient. Gray arrows with num
version of this figure is available at https://doi.org/10.1016/j.ijromoderate coefficient of determination, R2 Z 0.53 (Fig. 1A,
Fig. E2; available online at https://doi.org/10.1016/j.ijrobp.
2019.11.007). Applying the preset displacement factor of
1.5S to the original p- and p/sv-CTV positions in the
anterioreposterior direction resulted in shifts of 5 mm. In
the caudalecranial direction, this shift combined by the
regression resulted in shifts of 3 mm. Because 1.5S in the
righteleft direction resulted in a displacement of only 1
mm, it was neglected. The plan library, therefore, consisted
of 2 shifted p- and p/sv-CTV positions: (1) 5 mm posteri-
orly and 3 mm caudally referred to as “plan down” and (2)
5 mm anteriorly and 3 mm cranially referred to as “plan
up” (Fig. 1B, Fig. 2). In addition to the shifted targets, the
original position of the p- and p/sv-CTVs, denoted “plan
mid,” was included in the plan library. The PTV margin for
these targets, using 1.5S was 5 mm in the direction of the
largest residual motion. This expansion was applied to all
directions owing to other uncertainties, for example, from
delineation and intrafraction motion.
The motion described by the population model applied
to the margin recipe resulted in PTV margins of 3 mm in
the righteleft direction and 10 mm elsewhere for p- and
p/sv-CTVs of the conventional or backup plan. The 3 mm
margin in the righteleft direction purely derived from
motion were, using the same arguments on additional un-
certainties as for the margins applied to the plans in the
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escribe the position of the high-dose clinical target volume
lue). (B) Target positions as crosses together with prostate,
bers describe translations of the displaced CTVs. (A color
bp.2019.11.007).
Fig. 2. Examples of plan selection after the bony anatomy match of the repeat computed tomography to the plan computed
tomography in patient 20 (top), 23 (middle), and 25 (bottom). Selected plans are visualizedwith bold contours (left column),with
color coding the same as for Figure 1 and backup plan in gray. The dose distribution of the selected plans is shown with a 95%-
dose threshold (right column). (A color version of this figure is available at https://doi.org/10.1016/j.ijrobp.2019.11.007).
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tients, the large conventional margins of the nonadaptive
delivery led to the plan evaluation criteria for both rectum
and bladder being exceeded in 4 patients in addition to
being exceeded for either rectum or bladder in another 2
patients. The dosimetric results from the IMPT planning
further revealed that for plan down, the rectum criterion
was violated in 5 patients, whereas for plan up the bladder
criterion was exceeded in 5 patients. For plan mid, 1 patient
did not meet the bladder criterion.
Plan selection frequencies and dosimetric
comparison to the nonadaptive delivery
The most frequently selected plan across all patients was
plan mid (45%) followed by the backup plan (30%),
whereas plan down or plan up were less frequently used
(16% and 9%, respectively). Two patients never had the
backup plan selected, and no patients had both plan up and
plan down chosen during the PT course (Fig. 3). As for the
training patients, the difference in shifts from the GM- andBA-based registrations for the testing patients were corre-
lated in the anterioreposterior and cranio-caudal directions
(Fig. E3; available online at https://doi.org/10.1016/j.
ijrobp.2019.11.007). When comparing the selected plans
to the shifts in these directions the following patterns were
seen. Plan mid was selected for motion in any of these
directions <2 mm (true for 83% of these selections), plan
down or plan up were selected for the anterioreposterior
motion >2 mm (posteriorly for plan down and anteriorly
for plan up) and larger than the motion in the cranio-caudal
direction (true for 85% of these selections).
The treatment simulations showed significant (P < .001)
sparing of rectum gEUD from an average of 56  4
Gy(RBE) to 54  5 Gy(RBE) with plan selection (Fig. 4,
5). Also, rectum V60GyRBE was significantly decreased from
a median of 12 mL for the nonadaptive delivery to 9 mL
(P < .001) with adaptive approach leading to 20% fewer
rCTs where the plan criterion V60GyRBE < 10 mL was
violated. A significant dosimetric gain was also evident for
the bladder with the average gEUD and V45GyRBE being 54
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Fig. 3. Histogram of plan selection frequency in each of the testing patients.
Volume 106  Number 3  2020 Plan selection in proton therapy 635Gy(RBE) and 30% for adaptive delivery (P < .001) (Fig. 5).
The number of rCTs where the bladder planning criterion
was violated was reduced by almost 40% with plan selec-
tion compared with the nonadaptive delivery. For both the
small and large bowel, V45GyRBE were well below the
planning criteria. The gEUD for the large and small bowel
were however reduced by 4 Gy(RBE) using plan selection,
whereas no differences were seen for the high-dose regions
(V60GyRBE) (Fig. E4; available online at https://doi.org/10.
1016/j.ijrobp.2019.11.007).
The p/sv-CTV had the greatest improvement from the
adaptations with coverage (D98%) on average 1 Gy(RBE)
higher with plan selection compared with the nonadaptive
delivery (P < .001) (Fig. 3, 4). A slightly higher coverage
was also obtained for p/sv-CTV (Fig. 5). TheD98% for ln-CTV
was similar between the 2 delivery approaches, but whereas
the planning criterion of D98% > 47.5 Gy(RBE) was fulfilled
in all rCTs with plan selection, it was violated in 20% of the
rCTs with the nonadaptive delivery (Fig. E4; available online
at https://doi.org/10.1016/j.ijrobp.2019.11.007).Discussion
We have presented the potential of plan selection in IMPTof
multiple targets. With our method of plan library construc-
tion, the original prostate position of the pCTwould be most
frequently used and plan up and plan down dedicated to
outlier positions. This was also reflected in our results
with planmid beingmost frequently selected and with only 2
patients having the outlier plans selected for 50% or more of
the simulated fractions (Fig. 3). Plan mid was most
commonly the second-best match for the rCTs when the
backup plan was selected. Choosing a larger confidence
level by increasing the factor of the systematic error in
combination with increasing the PTV margins for the orig-
inal CTV position would be closer to the conventional
approach of delivery with the outlier plans selected less
frequently. In our study, the PTV expansion approximately
corresponded with the amount of shift applied to the outlier
positions, but no less than 5 mm and symmetrical owing to
other uncertainties, as discussed below. Also, the PTV
expansion was identical for all plans in the library, which is a
simplification because the systematic and randomcomponents may be different for the outlier positions
compared with the original position. Main reasons for
selecting the backup plan were geometric misses from plan
mid posteriorly or cranially. No obvious common cause for
the geometric misses was present, but target deformation
mainly owing to altered rectum shape, rotated pelvic, and
delineation uncertainties were contributions.
The plan libraries were based on a simple motion model
restricted to rigid translation of the p- and p/sv-targets in
relation to the BA. The seminal vesicles, however, undergo
deformations,23 yet delivery with plan selection resulted in
a high dose to this target (Fig. 5). Owing to deformations
and other uncertainties from intrafraction motion and
delineation, the smallest margins were set to 5 mm. Intra-
fraction motion for the prostate has been thoroughly studied
and reported to rarely be >5 mm.24,25 Delineation un-
certainties for the ln-CTV can be considerable,26 and to
limit these uncertainties, all target delineations were made
by 1 oncologist. Yet, a 5 mm margin may be considered at
the lower end of what is acceptable for the ln-CTV. The
motivation behind varying the position of the high-dose
target was the assumption that range uncertainties will be
limited by keeping the beam positions relative to BA con-
stant throughout the course of treatment. Alternatively, the
method used in this study could be applied for GM regis-
trations instead, with the residual motion of the ln-CTV
either handled by a larger PTV or by a plan library.
Dose degradation owing to BA variations for passive
scattering PT using lateral fields and image guidance on
prostate was reported by Trofimov et al, who found a
correlation of femur angle and distal proton range for their
target (prostate and seminal vesicles).1 BA alterations were
also found to contribute to reduced dose coverage of the
prostate and seminal vesicle target in passive scattering PT
using anterior-oblique fields with image guidance on
prostate.27 When comparing image guidance on BA versus
guidance on the prostate-rectal wall, Maeda et al found
superior or comparable target coverage for the latter.28 In
their study, the passive scattering technique was, however,
planned to compensate for prostate motion of 10 mm in
relation to the BA, which was more than the recorded
differences between the 2 setup techniques in their patient
material. In our training material, such large motion was
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Fig. 4. Dose-volume histograms for patient number 19. The top image displays the planning dose-volume histograms for
plan up (green), plan mid (orange), plan down (blue) and the nonadaptive plan also used for backup (gray). The bottom image
shows treatment simulations for plan selection (blue) and nonadaptive delivery (red). The different line patterns for targets
and organs at risk for both the top and bottom image are as described for the top image. (A color version of this figure is
available at https://doi.org/10.1016/j.ijrobp.2019.11.007).
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1016/j.ijrobp.2019.11.007).
Positioning onBA should bemore beneficial for the pelvic
lymph nodes because of their close location to the sacrum
and pelvic girdle.5 The ln-CTV was, however, the target with
largest dose degradation in the rCTs with 2 patients having
patient-average D98% CTV <95% of the prescribed dose
independent of delivery approach. The low-dose regions of
the ln-CTV were commonly in the caudal parts of the target,
at the boundary of the rectum and bladder. Our assumption
to limit range uncertainties solely through BA positioning
was, therefore, not sufficient for the ln-CTV. Reasons are
likely multifactorial, influenced by rotations of the pelvic or
femur and changes in body contour or bladder/rectum filling.For IMPT planning in the current version of our commercial
planning system, target specific margins in the proximal,
distal, and lateral direction was defined as a fixed distance
instead of relative. In comparison to other generic margins
(for passive scattering delivery), for example, 2.7% to 4.6%
þ 1.2 mm as in Paganetti29 the PT specific range margins
were around 2% for ln-PTV but closer to 1% in p- and
p/sv-PTV, whereas our setup/motion margins were greater.
Our margins were, however, comparable to previous studies
on prostate when combining the proximal and distal margins
with the PTV margins.30,31
Target specific range uncertainty margins and other
beam configurations could potentially have reduced the














































































Fig. 5. Dosimetric evaluation of the high-dose clinical target volume (top) and rectum and bladder (bottom). Subplots show
dose parameters for all repeat computed tomography in all patients from nonadaptive delivery (left) and plan selection (right).
Shaded regions represent interquartile range, black line the median, whiskers the 95% confidence interval, and circle/stars
outliers. For targets the dose to 98% of the clinical target volume (D98%), whereas for the organs at risk the generalized
equivalent uniform dose using a volume factor (k) of k Z 12 for the rectum and k Z 8 for the bladder are shown.
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length of protons have been investigated for a wide range of
beam angles.32 This study was conducted on patient ma-
terial (ie, pCT and rCTs) collected in the same trial as the
material of the current study. Interestingly, lateral fields
were, for the majority of the patients, associated with the
greatest proton range variations, and anterior oblique or
posterior oblique fields were found most robust.32 Anterior
oblique fields as compared to lateral opposed fields for
passive scattering PT to the prostate and proximal seminal
vesicles, were, however, found less robust to interfraction
motion.27
With the plan selection approach developed in the cur-
rent study, we obtained statistically significant lower gEUD
to the rectum, bladder, and the bowels, and we expect that
this could also translate into a clinical gain. However, the
clinical impact of the sparing would have to be investigated
through a clinical trial. Online adaptive replanning, instead
of plan selection, has a potential to further reduce the dose
to surrounding tissue. This, however, is more resource
intensive than plan selection and with still unresolvedtechnological challenges, for example, on imaging quality
for dose calculation and contouring.11 Plan selection in the
current study was facilitated from the use of predefined
contours of the targets in the rCTs. This could have affected
both the distribution of plans selected and the consistency
in the plan selection between different selectors, which was
high (>90%). As an alternative, the residual motion vector
as defined in the method could be used directly for
selecting the plan of the day. The selected plans on a scatter
plot of the residual motion for all testing patients is dis-
played in Figure E3 (available online at https://doi.org/10.
1016/j.ijrobp.2019.11.007). This vector can be derived
from CBCT or even from orthogonal kV-kV registered on
both GM- and BA-registrations. Using images with poorer
soft-tissue contrast do, however, limit evaluation of geo-
metric coverage caused by a deforming target. The addi-
tional resources in online replanning should also be
weighed against the clinical gain from the additional in-
terventions. With the recent advances in automatic plan-
ning, the resources needed for creating a plan library can be
considerably reduced.
Pilskog et al. International Journal of Radiation Oncology  Biology  Physics638Conclusions
Plan selection from plan libraries derived from a population
model of day-to-day motion was feasible for all testing pa-
tients. Compared with the nonadaptive delivery approach,
plan selection reduced dose to the rectum and bladder without
compromising coverage for the targets involved in the
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